Here are relevant reports on : kidney-bean-market
-
Catheters Market by Type (Cardiovascular (Electrophysiology, Coronary Balloon, IVUS/OCT), Intravenous (CVC, PIVC, Midline), Urological, Neurovascular), Indication (Cardiac, Vascular, Kidney, Blood Transfusion, IV Medication Delivery and Fluid Management) - Global Forecast to 2030
The global catheters market, valued at US$28.51 billion in 2024, stood at US$30.53 billion in 2025 and is projected to advance at a resilient CAGR of 8.5% from 2025 to 2030, culminating in a forecasted valuation of US$45.99 billion by the end of the period.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies)- Global Forecast to 2021
The global PEGylated proteins market size is projected to grow at a CAGR of 10.5%. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecule-targeted Microbubbles, Software], Application (Diagnostic, Therapeutic, CVDs, Liver, Kidney, Oncology), End User (Hospital, Clinics, ASCs) & Region - Global Forecast to 2028
The global contrast enhanced ultrasound market, valued at US$1.4 billion in 2022, stood at US$1.6 billion in 2023 and is projected to advance at a resilient CAGR of 6.1% from 2023 to 2028, culminating in a forecasted valuation of US$2.1 billion by the end of the period. The rising use of contrast agents, increasing partnerships and collaborations, and the introduction of novel technologies are expected to drive the market during the forecast period.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Lithotripsy Devices Market by Type (ESWL, Intracorporal (Laser, Electrohydraulic, Mechanical, Ultrasonic Lithotripsy)), Application (Kidney, Ureteral, Bile Duct & Pancreatic Stones), End User (Hospital), Procedures - Global Forecast to 2023
The global lithotripsy devices market is expected to reach USD 1.76 Billion by 2023, at a CAGR of 4.5%. Growth in this market is propelled by the increasing incidence of urolithiasis and technological advancements in lithotripsy devices. Some of the major players in the lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany). Key companies in the Lubricating Oil Additives market include Afton Chemical (US), Chevron Oronite (US), BASF (Germany), Evonik Industries (Germany), Lubrizol Corporation (US), and Lanxess (Germany).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Ureteral Stents Market by Type (Double Pigtail, Closed, Open, & Multiloop), Material (Metallic, Polyurethane, Silicon, & Hydrogel), Treatment Type (Kidney Stones, Kidney Transplant, & Urinary Incontinence), and End User (Hospitals, Ambulatory Surgical Centres) - Global Forecast to 2023
The global ureteral stents market is expected to reach USD 376.0 million by 2023 from USD 278.3million in 2018, growing at a CAGR of 6.2%. Increasing incidence of kidney diseases; rising adoption of minimally invasive surgeries; technological advancements in bio absorbable ureteral stents and rising number of kidney transplants are some of the major factors driving the growth of the global ureteral stents market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Plant-based Protein Market by Source (Soy, Wheat, Pea, Canola, Rice, Oats, Potato, Faba Bean), Type (Concentrates, Isolates, Textured, Milled Protein Flours, Starch-rich Protein Flours), Application, Nature, Form, Function, and Region - Global Forecast to 2030
The plant-based protein market is estimated at USD 23.89 billion in 2025 and is projected to reach USD 34.97 billion by 2030, at a CAGR of 7.9%. The plant-based protein market has experienced significant growth as consumers seek alternatives to traditional animal-derived protein sources. The report profiles key players such as Cargill, Incorporated (US), ADM (US), Kerry Group PLC (Ireland), International Flavors & Fragrances Inc. (US), Ingredion Incorporated (US), Wilmar International Ltd. (Singapore), Roquette Frères (France), Glanbia PLC (Ireland), DSM-Firmenich (Switzerland), AGT Food and Ingredients (Canada), Tate & Lyle (UK), Burcon (Canada), Emsland Group (Germany), PURIS (US), and COSUCRA (Belgium).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Fava Bean Protein Market by Product Type (Protein Isolate, Protein Concentrates, Flour), Nature Type (Organic, And Conventional), End-User (Food Processing, Infant Nutrition, Nutraceuticals, Animal Feed, and Others), and Region - Global Forecast to 2029
The global fava bean protein market growth is on a trajectory of significant expansion, with an estimated value projected to reach USD XX.X billion by 2029 from the 2024 valuation of USD XX.X billion, displaying a promising Compound Annual Growth Rate (CAGR) of X.X%. The key players in this market include Australian Plant Proteins (Australia), Ingredion (US), Roquette Frères (France), Prairie Fava (Canada), VESTKORN (Norway), AGT Food and Ingredients Inc (Canada), Puris (US), MartinBauer (Germany), Nuttee Bean Co. (US), GrainCorp (Australia), Deltagen Ltd (UK), Cargill Incorporated (US).
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Offering (Models, Service), Type (Liver, Kidney, Heart), Culture Type (ECM, Suspension), Source (ASCs, ESCs), Disease Area (Oncology, GI, Neurology), Application (Screening, Toxicity, Efficacy), End User - Global Forecast to 2031
The global human organoids market is projected to reach USD 0.90 billion by 2031, growing at a CAGR of 25.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User [Profit (Pharma, Payer, Hospital), Non-profit (Govt)], and Region - Global Forecast to 2031
The global patient registry software market is projected to reach USD 3.99 billion by 2031, growing at a CAGR of 10.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Organ-on-Chip Market by Organ Type (Liver, Kidney, Intestine, Lung, Heart), Products (Instruments, Consumable, Software), Services (Standard, Custom), Model Type, Application (Toxicology, Drug Discovery, Stem Cell), Purpose & Region - Global Forecast to 2029
The global organ-on-chip market, valued at US$89,202 thousand in 2023, stood at US$123,285 thousand in 2024 and is projected to advance at a resilient CAGR of 38.6% from 2024 to 2029, culminating in a forecasted valuation of US$631,073 thousand by the end of the period Growth in this market can mainly be attributed to the increasing government initiatives to reduce drug testing on animal models.
- Published: February 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50